尼尔塞维马布和急性支气管炎在儿科急诊室的发作
David Andina Martínez1,2, Gemma Claret Teruel3,4,5, Manuel Gijón Mediavilla6
1Pediatric Emergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Pediatrics
|September 11, 2024
概括
全球尼尔塞维马布预防在婴儿中显著减少呼吸道同胞病毒 (RSV) 感染. 这种普遍的RSV免疫策略,包括延长追赶时间,在预防下呼吸道感染和住院治疗方面非常有效.
科学领域:
- 儿童传染病 儿童传染病
- 免疫接种策略 免疫接种策略
- 公共卫生干预措施 公共卫生干预措施
背景情况:
- 西班牙在2023-2024年呼吸道同胞病毒 (RSV) 季节实施了婴儿的普遍尼尔塞维马布预防.
- 许多地区还为6个月以下的婴儿提供了延长的追赶免疫接种.
- 这项研究评估了RSV预防对急性呼吸道感染的儿科急诊室访问的影响.
研究的目的:
- 评估使用nirsevimab的全方位RSV预防对婴儿急诊室呈现的效果.
- 为了比较RSV相关的疾病率之前和之后的广泛实施nirsevimab.
- 评估不同预防方法的有效性,包括扩展的追赶计划.
主要方法:
- 一项回顾性研究分析了来自9个地区的15个西班牙儿科急诊室的数据.
- 这项研究将2018-2023年的流行季节与2023-2024年的流行季节进行了比较.
- 关键指标包括下呼吸道感染,急性支气管炎发作,住院和PICU入院.
主要成果:
- 在2023-2024年观察到显著下降:下呼吸道感染减少57.7%,急性支气管炎发作减少59.2%.
- 急性支气管炎住院人数下降了63.1%,PICU住院人数也下降了63.1%.
- 采用扩展追赶免疫战略的地区表现出更好的结果.
结论:
- 尼尔塞维马布为广泛的婴儿群体提供了高度有效的防护RSV.
- 普遍预防,特别是与延长的追赶计划相结合时,是最有效的策略.
- 对于广泛实施,成本效益方面的考虑仍然很重要.
更多相关视频
相关概念视频
01:29Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K